Skip to main content

CORRECTION article

Front. Immunol., 10 November 2021
Sec. Molecular Innate Immunity
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.804228

Corrigendum: Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis

This article is a correction to:

  1. Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis

    1. Read original article
Yue Qiu,&#x;Yue Qiu1,2†Yirui Cao,&#x;Yirui Cao3,4†Guowei Tu&#x;Guowei Tu1†Jiawei Li,Jiawei Li3,4Ying SuYing Su1Fang FangFang Fang2Xuepeng Zhang,Xuepeng Zhang1,2Jing Cang*Jing Cang2*Ruiming Rong,*Ruiming Rong3,4*Zhe Luo,*Zhe Luo1,5*
  • 1Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
  • 2Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China
  • 3Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China
  • 4Shanghai Key Laboratory of Organ Transplantation, Shanghai, China
  • 5Department of Critical Care Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China

A Corrigendum on:
Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis

By Qiu Y, Cao Y, Tu G, Li J, Su Y, Fang F, Zhang X, Cang J, Rong R and Luo Z (2021) Front. Immunol. 12:698894. doi: 10.3389/fimmu.2021.698894

In the published article, there was an error regarding the affiliation for author Jing Cang. Instead of “4”, it should be “2”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: renal fibrosis, CCL5, CCR5, migration, myeloid-derived suppressor cells

Citation: Qiu Y, Cao Y, Tu G, Li J, Su Y, Fang F, Zhang X, Cang J, Rong R and Luo Z (2021) Corrigendum: Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis. Front. Immunol. 12:804228. doi: 10.3389/fimmu.2021.804228

Received: 29 October 2021; Accepted: 29 October 2021;
Published: 10 November 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Qiu, Cao, Tu, Li, Su, Fang, Zhang, Cang, Rong and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jing Cang, cang.jing@zs-hospital.sh.cn; Ruiming Rong, rong.ruiming@zs-hospital.sh.cn; Zhe Luo, luo.zhe@zs-hospital.sh.cn

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.